Changes in domain-specific neutralization sensitivities of subtype B HIV-1 Envs over time.
Domain:
healthcareRecord type:
paper
Creator:
LinEriMicEri
Host:
For each neutralizing antibody (NAb), the geometric mean (GM) IC50 and percentage of pseudoviruses (PSVs) neutralized, was determined for all PSVs from each decade period, as shown in Fig 3. The trends for NAb potency (A-D) and breath (F-I) over time are shown by NAb specificity, including (A and F) V1V2 specific NAbs, (B and G) V3 NAbs, (C and H) CD4bs NAbs and (D and I) MPER NAbs. This neutralization analysis was repeated using 33 subtype B HIV+ plasma samples against PSVs from each decade period; the (E) GM ID50 and (J) percentage of PSVs neutralized, was determined for all PSVs from each decade. Significant differences were determined by Wilcoxon matched-pairs signed rank test; * = p<0.01, ** = p<0.001, *** = p<0.0001.
Similar
Immune exposure to a specific sequence of antibody escape variants could program long-term potential for neutralization breadth in subtype A HIV-1 infection (P6161)Distinct amino acid signatures and neutralization sensitivity of plasma- and CSF-derived HIV-1 subtype C clonesHIV-1 Subtype Distribution and Diversity Over 18 Years in Rakai, UgandaAdditional file 1 of Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AGComparison of the neutralization sensitivity of South African and Indian HIV-1 subtype C viruses to South African plasma antibodiesAffordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.